Clinical Trials Logo

Clinical Trial Summary

On a population of patients followed by an office-based cardiologist and treated with eplerenone, the objectives of the survey are:

- To describe the characteristics of the population treated.

- To describe the methods of use of eplerenone (posology, duration of treatment, medicinal combinations).

- To describe the follow-up methods of the treatment.

- To describe the possible interruptions of the treatment


Clinical Trial Description

A sample size in the region of N = 400 patients will allow this accuracy of estimation, as for this size, the half-width would be equal to 5% for a frequency of 50% corresponding to a confidence interval of maximum width. In view of the type of survey and the need for 12 months of monitoring in the context of standard practice, it may be anticipated that the drop-off rate will be about 20%. A sample size of N = 500 patients was therefore chosen. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01440049
Study type Observational
Source Pfizer
Contact
Status Completed
Phase
Start date September 2008
Completion date December 2010